DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies.
A double fluorescence assay has been employed for the detection of cell surface and/or cytoplasmic immunoglobulins (Ig) and the measurement of nuclear DNA content in the same cell. Following staining for Ig by means of FITC conjugated antibodies directed against heavy or light chains, cell suspensions or cytospin preparations were ethanol fixed and stained with a propidium iodide-RNAse solution. In this way, the cytometric DNA content of circulating B-lymphocytes was analyzed in three patients suffering from plasma cell malignancies with an excess of peripheral blood B-lymphocytes and evidence of aneuploid bone marrow plasma cells. Aneuploid circulating B-lymphocytes with the same DNA stem-line as bone marrow plasma cells were found in two patients with advanced disease but not in the only one we studied at presentation. Aneuploid lymphocytes had surface immunoglobulins bearing the same light chain as the M-protein. In addition, a significant percentage (23%) of cells lacking either surface or cytoplasmic immunoglobulins proved to be aneuploid in plasma cell leukemia. Nuclear DNA measurement combined with surface or cytoplasmic marker analysis appears to be a reliable method for studying neoplastic lymphoid precursor cells in plasma cell malignancies.
D000782:Aneuploidy; D001402:B-Lymphocytes / Q000378:metabolism*; D001853:Bone Marrow / Q000378:metabolism; D003593:Cytoplasm / Q000032:analysis; D004273:DNA, Neoplasm / Q000378:metabolism*; D005434:Flow Cytometry; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000378:metabolism; D009101:Multiple Myeloma / Q000378:metabolism; D011947:Receptors, Antigen, B-Cell / Q000032:analysis
D004273:DNA, Neoplasm; D011947:Receptors, Antigen, B-Cell